Home > Browse Issues > Vol.48 No.11

Dexmedetomidine Regulates the miR-199a-5p/G6PD Pathway to Induce Ferroptosis and Suppress Malignant Phenotypes in Colorectal Cancer Cells


ZHAO Congwei1, MA Tao1*, FENG Pei1, CHI Hongxin2, DONG Jiali1

(1Department of Anesthesiology, Cangzhou People’s Hospital, Cangzhou 061000, China; 2Department of Anesthesiology, Hebei Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Cangzhou 061000, China)
Abstract:

This work was to investigate the effects of DEX (dexmedetomidine) on proliferation, migration, invasion, and ferroptosis of colorectal cancer cells, and to elucidate the potential mechanisms of the miR-199a 5p/G6PD (glucose-6-phosphate dehydrogenase) axis in this process. Human colorectal cancer cell lines HT29 and SW480 were used for in vitro experiments. Cell viability was assessed by CCK-8 assay; colony formation assay was used to evaluate cell proliferation; wound healing and Transwell assays were performed to detect cell migra tion and invasion, respectively; Western blot was employed to detect the expression levels of EMT (epithelial mesenchymal transition)-related proteins, including E-cadherin (epithelial cadherin), N-cadherin (neural cadherin), and Snail1 (snail family transcriptional repressor 1), as well as ferroptosis-related proteins, including  GPX4 (glu tathione peroxidase 4), SLC7A11 (solute carrier family 7 member 11), NRF2 (nuclear factor erythroid 2-related factor 2), and TFRC (transferrin receptor protein 1); intracellular ROS (reactive oxygen species) levels were mea sured by fluorescence probe method; GSH (glutathione) content was detected by colorimetric method; intracel lular Fe2+ levels were measured by fluorescence probe method; the ferroptosis inhibitor Fer-1 (ferrostatin-1) was used for intervention validation. The mRNA expression levels of miR-199a-5p and G6PD were detected by real time quantitative PCR; dual-luciferase reporter assay was performed to verify the targeting relationship between miR-199a-5p and G6PD. Cell groups were as follows: control group (Con), DEX-treated group (100 ng/mL, 24 h), DEX+miR-199a-5p mimic group, DEX+miR-199a-5p inhibitor group, DEX+G6PD overexpression group, and cor responding negative control transfection groups. Compared with the control group, the DEX-treated group showed significantly decreased cell viability, colony formation number, and numbers of migrating and invading cells in both HT29 and SW480 cells (all P<0.01), significantly increased E-cadherin protein expression level (P<0.001), and significantly decreased N-cadherin and Snail1 protein expression levels (both P<0.001); ROS fluorescence intensity and Fe2+ fluorescence intensity were significantly increased (both P<0.001), while GSH content was significantly decreased (P<0.001); the protein expression levels of GPX4, SLC7A11, and NRF2 were significantly decreased (all P<0.001), whereas TFRC protein expression level was significantly increased (P<0.001); Fer-1 intervention signifi cantly reversed the DEX-induced decrease in cell viability (P<0.001). Compared with the control group, the DEX treated group exhibited significantly increased miR-199a-5p expression level (P<0.001) and significantly decreased G6PD mRNA expression level (P<0.001); dual-luciferase reporter assay confirmed that miR-199a-5p could directly target the 3′-untranslated region of G6PD mRNA. Compared with the DEX-treated group, the G6PD overexpression group showed significantly increased cell viability, colony formation number, and numbers of migrating and invading cells (all P<0.01), significantly decreased E-cadherin protein expression level (P<0.001), and significantly increased N-cadherin and Snail1 protein expression levels (both P<0.001); ROS fluorescence intensity and Fe2+ fluorescence intensity were significantly decreased (both P<0.001), while GSH content was significantly increased (P<0.001); the protein expression levels of GPX4, SLC7A11, and NRF2 were significantly increased (all P<0.001), whereas TFRC protein expression level was significantly decreased (P<0.001). DEX upregulates miR-199a-5p in colorectal cancer cells, which in turn targets and suppresses G6PD, thereby disrupting cellular antioxidant defense and inducing fer roptosis. Activation of ferroptosis serves as a key mediating mechanism through which DEX inhibits the prolifera tion, migration, and invasion of colorectal cancer cells. These findings suggest that the miR-199a-5p/G6PD axis is a potential regulatory node underlying the ferroptosis-inducing and anti-colorectal cancer effects of DEX.


CSTR: 32200.14.cjcb.2026.11.0005